New insights into the pathogenicity of leptospires: Evasion of host defences

New Microbiologica

Volumn 33, Issue 4, 2010, Pages 283-292

  Cinco, Marina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Adhesion; Leptospires; Lipoproteins; Pathogenicity

Indexed keywords

BACTERIAL PROTEIN; LIPOPROTEIN; VIRULENCE FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIUM ADHERENCE; CLASSIFICATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; LEPTOSPIRA; LEPTOSPIROSIS; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY; PHYSIOLOGY;

ANIMALS; BACTERIAL ADHESION; BACTERIAL PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; LEPTOSPIRA; LEPTOSPIROSIS; LIPOPROTEINS; PHYLOGENY; VIRULENCE FACTORS;

LEPTOSPIRA; LEPTOSPIRA INTERROGANS;

EID: 78650251929     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. ATZINGEN M.V., BARBOSA A.S., DE BRITO T., VASCONCELLOS S.A, DE MORAIS Z.M., LIMA .M, ABREU P.A., NASCIMENTO A.L. (2008). Lsa 21, a novel leptospiral protein binding adhesive atrix molecules present during human infection. BMC Microbiol. 29, 8-70.
2. BANFI E., CINCO M., BELLINI M., SORANZO M.R. (1982). Studies on the interaction between macrophages and leptospires. II. The role of antibodies and complement. J. Gen. Microbiolog. 128, 813-816.
3. BARBOSA A.S, ABREU P.A., NEVES F.O., ATZINGEN M.V., WATANABE M.M., VIEIRA M.L., MORAIS Z.M., VASCONCELLOS S.A., NASCIMENTO A.L. (2006). A newly identified leptospira adhesin mediates attachment to laminin. Infect. Immun. 11, 6356-6364.
4. BARBOSA A.S., ABREU P.A., VASCONCELLOS S.A., MORAIS Z.M., GONÇALES A.P., SILVA A.S., DAHA M.R., ISAAC L. (2009). Immune evasion of Leptospira species by acquisition of human Complement regulatort C4BP. Infect. Immun. 77, 1137-1143.
5. BAROCCHI M.A., KO A.L, REIS M.G., DONALD M.C., RILEY L.W. (2002). Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but non intracellular pathogen. Infect. Immun 70, 6926-6932.
6. BHARTI A.R., NALLY J.E., RICALDI J.N., MATTHIAS M.A., DIAZ M.M., LOVETT M., LEVETT P.N., GILMAN R.H., WILLIG M.R., GOTUZZO E., VINETZ J. M. (2003). Leptospirosis: a zoonotic diseases of global importance. Lancet Infect. Dis. 3, 757-771.
7. BLASI E., ARDIZZONI A., COLOMBARI B., NEGLIA R., BASCHIERI C., PEPPOLONI S., CINCO M. (2007). NFkB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins. Microb. Pathog. 42, 80-87.
8. Blom A.M. Structural and functional studies of complement inhibitor C4b-binding protein Biochemical Society Transactions 2002 30 6 978-982 DOI 10.1042/BST0300978 BLOOM A.M. (2002). Structural and functional studies of complement inhibitor C4b binding protein. Biochem. Soc.Trans. 30, 978-982. (Pubitemid 36002391)
9. BREINER D.D., FAHEY M., SALVADOR R., NOVAKOVA J., COBURN J. (2009). Leptospira interrogans binds to human Cell Surface Receptors including proteoglycans. Infect. Immun. 77, 5528-5536.
10. CDC. 12 October 2005.revision date.Leptospirosis.CDC, AtIanta,GA.http://www.cdc.gov/ncidof/dbmd/diseaseinfo/leptospirosis-g.htm
11. CHOY H.A., KELLEY M.M., CHEN T.L., MOLLER A.K., MATSUNAGA J., HAAKE D.A. (2007). Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 75, 2441-2450.
12. CINCO M., BANFI E. (1983). Interaction between human polymorphoniclear leucocytes and one strani of pathogenic Leptospira and one strani of saprophytic Leptospira (L. biflexa). FEMS Microbiol Lett 19, 51-54.
13. Cinco M. Banfi E. Activation of complement by leptospires and its bactericidal activity Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene - Abt. 1 Orig. A 1983 254 2 261-265 CINCO M., BANFI E. (1983). Activation and Bactericidal activity of Complement by leptospires. Zbl. Bakt. Hyg. I. Abt. Orig. A 254, 261-265. (Pubitemid 13071446)
14. CINCO M., BANFI E., SORANZO M.R. (1981). Studies on the interaction between macrophages and leptospires. J. Gen Microbiol 124, 409-413.
15. CINCO M., CINI B., PERTICARARI S., PRESANI G. (2002). Leptospira interrogans binds the CR3 receptor on mammalian cells. Microb. Pathog. 33, 299-305.
16. CINCO M., DOMENIS R., PERTICARARI S., PRESANI G., MARANGONI A., BLASI E. (2006). Interaction of Leptospires with murine microglial cells. New Microbiologica 29, 193-199.
17. Cinco M. Vecile E. Murgia R. Dobrina P. Dobrina A. Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor α from human monocytes FEMS Microbiology Letters 1996 138 2 3 211-214 DOI 10.1016/0378-1097(96)00109-7 CINCO M., VECILE E., MURCIA R., DOBRINA P., DOBRINA A. (1996). Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes. FEMS Microbiol Lett. 138, 211-214. (Pubitemid 26183263)
18. CRODA J., RAMOS J.G., MATSUNAGA J., QUEIROZ A., HOMMA A., RILEY L.W., HAAKE D.A, REIS M.G., KO A.I. (2007). Leptospira immunoglobulin- like proteins as a sérodiagnostic marker for acute leptospirosis, J. Clin. Microbiol. 45, 1528-1534.
19. CULLEN RA, XU X., MATSUNAGA J., SANCHEZ Y., KO A.I., HAAKE D.A., ADLER B. (2005). Surfaceoma of Leptospira spp. Infect. Immun. 73, 4853-4863.
20. CULLEN P.A., CORDWELL S.J., BULACH D.M., HAACKE D.A., ADLER B. (2002). Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect. Immun. 70, 1211-1218.
21. ESHGHI A., CULLEN P.A., COWEN L., ZUERNER R.L., CAMERON C.E. (2009). Global protome Analysis of Leptospira interrogans. J. Proteome Res. 2, 4564-4578.
22. nd ed. MediSci. Melbourne, Australia.
23. GIGU I.T., FUJITA T., NUSSERZWEIG V. (1979). Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. USA 76, 6596-6600.
24. HAAKE D.A., CHAMPION C.I., MARTINICH C., SHANG E.S., BLANCO D.R., MILLER J.N., LOVETT M.A. (1993). Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp. J. Bacteriol. 175, 4225-4234.
25. HOKE D.E., EGAN S,. CULLEN P.A., ADLER B. (2008). LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect. Immun. 76, 2063-2069.
26. International Committee on Systematics of Prokaryotes: Subcommittee on the Taxonomy of Leptospiraceae. (2008). Intern J of Systematic and Evolutionary Microbiol. 58, 1049-1050.
27. JOHNSON R.C., HARRIS V.G. (1967). Antileptospiral activity of serum.II. Leptospiral virulence factor. J. Bacteriol. 3, 513-519.
28. JOHNSON R.C., HARRIS V.G. (1966). Antileptospiral activity of serum.I.Normal and immune serum. J .Bacteriol. 91, 1403-1409.
29. KLIMPEL G.R., MATTHIAS M.A., VINETZ J.M. (2003). Leptospira interrogans activation of human peripheral blood mononuclear cells: Preferential expansion of TCRgamma delta + cells vs TCR alpha beta+ T cells. J. Immunol. 171, 1447-1455.
30. KOIZUMI N., WATANABE H. (2004). Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22, 1545-1552.
31. LEE S.H., KIM K.A., PARK Y.G., SEONG I.W., KIM M.J., LEE Y.J. (2000). Identification and partial characterization of a novel hemolysin from Leptospira interrogans serovar lai. GENE. 254, 19-28.
32. LIN Y., CHANG Y.F. (2007). A domain of the Leptospira LigB contributes to high affinità binding of fibronectin. Biochem Bhiophys Res Commun. 362, 443-440.
33. LIU Y., ZHENG W., LI L., MAO Y, YAN J. (2007). Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells. Med. Microbiol. Immunol. 196, 233-239.
34. MATSUNAGA J., LO M., BULACH D.M., ZUERNER R.L., ADLER B., HAAKE D.A. (2007). Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the enviroment-to host transition. Infect. Immun. 75, 2864-2874.
35. MCBRIDE A.J., ATHANAZIO D.A., REIS M.G., KO A.I. (2005). Leptospirosis. Curr Opin Infect Dis. 18 (5), 376-386.
36. MERI T., MURCIA R., STEFANEL P., MERI S., CINCO M. (2005). Regulation of complement activation at the C3 level by serum resistant leptospires. Microb Pathog 39, 139-147.
37. MERIEN F., TRUCCOLO J., BARANTON G., PEROLAT P. (2000). Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol. Lett. 185, 17-22.
38. MERIEN F., TRUCCOLO J., ROUGIER Y., BARANTON G., PEROLAT P. (1998). In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett. 169, 95-102.
39. MERIEN F., BARANTON G., PEROLAT P. (1997). Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun. 65, 729-738.
40. MURGIA R., GARCIA R., CINCO M. (2002). Leptospirae Are Killed In Vitro by Oxygen-Dependent and Independent Reactions. Infect. Immun. 70, 7172-7175.
41. MURRAY G.L., SRIKRAM A., HOKE D.E., WUNDER E.A. JR, HENRY R., LO M., ZHANG K., SERMSWAN R.W, KO A.L, ADLER B. (2009). Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect. Immun. 77, 952-958.
42. NALLY J.E., WHITELEGGE R., AGUILERA M.M., PEREIRA D., BLANCO R., LOVETT M.A. (2005). Purification and proteomic analysis of outer membrane vesicles from a clinical isolate of Leptospira interrogans serovar Copenhageni. Proteomics 5, 144-152.
43. NALLY J.E., WHITELEGGE J.P., BASSILIAN S., BLANCO D.R., LOVETT M. (2007). Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect. Immun. 75, 766-773.
44. NASCIMENTO A.L, KO A.I, MARTINS E.A., MONTEIROVITORELLO C.B., HO PL., HAAKE D.A., VERJOVSKIALMEIDA S., HARTSKEERL R.A., MARQUES M.V, OLIVEIRA M.C., MENCK C.F., LEITE L.C., CARRER H., COUTINHO L.L., DEGRAVE W.M., DELLAGOSTIN O.A., EL-DORRY H., FERRO E.S., FERRO M.I., FURLAN L.R., GAMBERINI M., GiGLiOTi E.A., GÓES-NETO A., GOLDMAN G.H., GOLDMAN M.H., HARAKAVA R., JERÓNIMO S.M., JUNQUEIRA-DE-AZEVEDO I.L., KIMURA E.T., KURAMAE E.E., LEMOS E.G., LEMOS M.V., MARINO CL., NUNES L.R., DE OLIVEIRA R.C, PEREIRA G.G., REIS M.S., SCHRIEFER A., SIQUEIRA W.J., SOMMER P., TSAI S.M., SIMPSON A.J., FERRO J.A., CAMARGO L.E., KITAJIMA J.P., SETÚBAL J.C., VAN SLUYS M.A. (2004 ). Comparative genomics of two Leptospira interrogans serovars reveals novel insight into physiology and pathogenesis. J. Bacteriol. 186 (7), 2164-2172.
45. OLIVEIRA T.R., LONGHI M.T., GONÇALES A.P., DE MORAIS Z.M., VASCONCELLOS S.A., NASCIMENTO A.L. (2010). LipL53, a temperature regulated protein from Leptospira interrogans that binds to extracellular matrix molecules. Microb. Infect. 3, 207-217.
46. PATARAKUL K., LO M., ADLER B. (2010). Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiology, 10, 31-38.
47. PINNE M., HAAKE D.A. (2009). A comprehensive approach to identification of surface-exposed, Outer Membrane-spanning proteins of Leptospira interrogans. Plos One, 4, e6071.
48. QUE-GEWIRTH N.L., RIBEIRO A.A., KALB S.R., COTTER R.J., BULÁCH D.M., ADLER B., GIRONS LS., WERTS C., RAETZ C.R. (2004). A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J. Biol. Chem. 279, 25420-25429.
49. RAUTEMAA R., MERI S. (1999). Complement resistance mechanisms of bacteria. Microb. Infect. 1, 785-794.
50. RISTOW P., BOURHY P., KERNEIS S., SCHMITT C., PRÉVOST M.C., LILENBAUM W, PICARDEAU M. (2009). Biofilm formation by pathogenic and saprophytic Leptospira. Microbiology. 154, 1309-1317.
51. SAMBRI V., MARANGONI A., GIACANI L., GENNARO R., MURGIA R., CEVENINI R., CINCO M. (2002). Comparative in vitro activity of five cathelicidinderived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J. Antimicrob. Chemother. 50, 895-902.
52. SCOCCHI D., ROMEO D., CINCO M. (1993). Antimicrobial activity of two bactenecins against Spirochetes: L. interrogans, L. biflexa and Borrelia burgdorferi. Infect. Immun. 61, 3081-3083.
53. Setubal J.C. Reis M. Matsunaga J. Haake D.A. Lipoprotein computational prediction in spirochaetal genomes Microbiology 2006 152 1 113-121 DOI 10.1099/mic.0.28317-0 SETUBAL J.C., REIS M.G., MATSUNAGA J., HAAKE D.A. (2006). Lipoprotein computational prediction in spirochaetal genomes. Microbiology 152, 113-121. (Pubitemid 43092399)
54. SHANG E.S., EXNER M.M., SUMMERS T.A., MARTINICH C., CHAMPION C.I., HANCOCK R.E., HAAKE D.A. (1995). The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect Immun. 63, 3174-3181.
55. SLACK A.T., KHAIRANI-BEJO S., SYMONDS M.L., DOHNT M.F., GALLOWAY R.L., STEIGERWALT A.G., BAHAMAN A.R., CRAIG S., HARROWER B.J., SMYTH L.D. (2009). Leptospira kmetyi sp.nov., isolated from an enviromental source in Malaysia. Int J Syst Evol Microbiol. 59, 705-708.
56. STEVENSON B., CHOY H.A., PINNE M., ROTONDI M.L., MILLER M.C., DEMOLL E., KRAICZY P., COOLEY A.E., CREAMER T.P., SUCHARD M.A., BRISSETTE C.A., VERMA A., HAAKE D.A. (2007). Leptospira interrogans endostatin-like outer membrane protein bind host fibronectin, laminin and regulators of complement. PLoS One 14, 1188.
57. Tajiki M.H. Saloniao R. Association of plasma levels of tumor necrosis factor α with severity of disease and mortality among patients with leptospirosis Clinical Infectious Diseases 1996 23 5 1177-1178 TAJIKI H., SALOMÃO R. (1996). Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin. Infect. Dis. 23, 1177-1178. (Pubitemid 26367512)
58. THOMAS D.D., BASEMAN J.B., ALDERETE J.F. (1985). Fibronectin tetrapeptide is target for syphillis spirochete cytadherence. J. Exp. .Med. 162, 1715-1719.
59. THOMAS D.D., HIGHBLE L.M. (1990). In vitro association of Leptospires with host cells. Infect. Immun. 58, 581-585.
60. THONGBOONKERD V., CHIANGJONG W., SAETUN P., SINCHAIKUL S., CHEN S.T., KOSITANONT U. (2009). Analysis of differential proteomes in pathogenic and non-pathogenic Leptospira: potential pathogenic and virulence factors. Proteomics 13, 3522-3534.
61. TRUCCOLO, J., SERAIS, O., MERIEN, F., PEROLAT, P. (2001). Following the corse of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol. Lett. 204, 317-321
62. VERMA A., BRISSETTE C.A., BOWMAN A.A., SHAH S.T., ZIPFEL P.F., STEVENSON B. (2010). Leptospiral endostatin-like protein Len A is a bacterial cell-surface receptor for human plasminogen. Infect. Immun, in press.
63. VERMA A., HELLWAGE J., ARTIUSHIN S., ZIPFEL P.F., KRAICZY P., TIMONEY J.F., STEVENSON B. (2006). LfhA, a novel Factor H-binding protein of Leptospira interrogans. Infect. Immun. 74, 2659-2666.
64. VERNEL-PAUILLAC F., MERIEN F. (2006). Proinflammatory and Immunomodulatory cytokine mRNA time corse profile in hamsters infected with a virulent variant of Leptospira interrogans. Infect. Immun. 74, 4172-4179.
65. VIEIRA M,.L., PIMENTA D.C., DE MORAIS Z.M., VASCONCELLOS S.A., NASCIMENTO A.L. (2009). Proteoma analysis of Leptospira interrogans virulent strain.Open Microbiol. J. 3, 69-74.
66. WERTS C., TAPPING R.I., MATHISON J.C., CHUANG T.H., KRAVCHENKO V., SAINT GIRONS I., HAAKE D.A., GODOWSKI P.J., HAYASHI F., OZINSKY A., UNDERHILL D.M., KIRSCHNING C.J., WAGNER H., ADEREM A., TOBIAS P.S., ULEVITCH R.J. (2001). Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol. A (4), 346-352.